Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Gallacher

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Drugs|August 26, 2020
Correction to: Management of Hypertension in Chronic Kidney DiseaseDan Pugh, Peter J Gallacher, Neeraj Dhaun
Drugs|February 14, 2019
Management of Hypertension in Chronic Kidney DiseaseDan Pugh, Peter J Gallacher, Neeraj Dhaun
European Heart Journal|March 1, 2024
Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish studyPeter J Gallacher, David Yeung, Samira Bell, et al.
Journal of the American Heart Association|September 28, 2021
Infective Endocarditis Hospitalizations and Outcomes in Patients With End-Stage Kidney Disease: A Nationwide Data-Linkage StudyPeter J Gallacher, David A McAllister, Nicholas L Mills, et al.
The European Respiratory Journal|May 13, 2022
Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage studyEmilie J Lambourg, Peter J Gallacher, Robert W Hunter, et al.
Magnetic Resonance Imaging|November 11, 2011
Automatic segmentation of brain white matter and white matter lesions in normal aging: comparison of five multispectral techniquesMaria Del C Valdés Hernández, Peter J Gallacher, Mark E Bastin, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 2019
Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney DiseaseTariq E Farrah, Atul Anand, Peter J Gallacher, et al.
Rheumatology (Oxford, England)|December 4, 2019
Long-term outcomes in elderly patients with ANCA-associated vasculitisDominic McGovern, Sam P Williams, Katrina Parsons, et al.
British Journal of Clinical Pharmacology|June 24, 2022
Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney functionDuuamene Nyimanu, Fiona A Chapman, Peter J Gallacher, et al.
Nature Communications|August 25, 2024
<sup>18</sup>F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitisDan Pugh, Dilip Patel, Gillian Macnaught, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Drugs|August 26, 2020
Correction to: Management of Hypertension in Chronic Kidney DiseaseDan Pugh, Peter J Gallacher, Neeraj Dhaun
Drugs|February 14, 2019
Management of Hypertension in Chronic Kidney DiseaseDan Pugh, Peter J Gallacher, Neeraj Dhaun
European Heart Journal|March 1, 2024
Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish studyPeter J Gallacher, David Yeung, Samira Bell, et al.
Journal of the American Heart Association|September 28, 2021
Infective Endocarditis Hospitalizations and Outcomes in Patients With End-Stage Kidney Disease: A Nationwide Data-Linkage StudyPeter J Gallacher, David A McAllister, Nicholas L Mills, et al.
The European Respiratory Journal|May 13, 2022
Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage studyEmilie J Lambourg, Peter J Gallacher, Robert W Hunter, et al.
Magnetic Resonance Imaging|November 11, 2011
Automatic segmentation of brain white matter and white matter lesions in normal aging: comparison of five multispectral techniquesMaria Del C Valdés Hernández, Peter J Gallacher, Mark E Bastin, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 2019
Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney DiseaseTariq E Farrah, Atul Anand, Peter J Gallacher, et al.
Rheumatology (Oxford, England)|December 4, 2019
Long-term outcomes in elderly patients with ANCA-associated vasculitisDominic McGovern, Sam P Williams, Katrina Parsons, et al.
British Journal of Clinical Pharmacology|June 24, 2022
Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney functionDuuamene Nyimanu, Fiona A Chapman, Peter J Gallacher, et al.
Nature Communications|August 25, 2024
<sup>18</sup>F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitisDan Pugh, Dilip Patel, Gillian Macnaught, et al.
Pageof 2